The injectable drug delivery method is an important tool used by medical professionals to provide a drug dose to a patient directly through his body, thereby reducing the threat of overdose, and streamlining drug release. Such a system leverages a faster and more controlled drug release into the bloodstream. WILMINGTON, Del.
, July 15, 2024 /PRNewswire/ -- The projected size of the global injectable drug delivery system market is likely to reach USD 1.9 trillion by 2034. This advancement of the industry is estimated to reach this value at a promising CAGR of 9.
8% through the forecasted period, which lifted the valuation from the USD 689.5 billion mark, measured in 2023. The spurring incidences of patients affected due to chronic diseases are likely to affect the size of the competitive space.
With the rising prevalence of diseases, the demand for relevant drugs, medicines, and medical assistance is expected to proliferate in the forecast period. The cases of patients infected due to several infectious diseases like malaria and influenza are increasing. To cater to the effective medication demand, medical professionals are investing more in the development of appropriate drugs and suitable drug delivery methods and systems.
Along with such infectious diseases, chronic illnesses like cancer, cardiovascular diseases, pulmonary disorders, and many more are expected to spread rapidly. This accelerated prevalence of diseases is expected to drive the demand for the appropriate drug .
